Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000242531 is annotated as a pseudogene that contains WD repeat domains. Pseudogenes are generally non-functional genomic DNA sequences similar to normal genes but typically lack the ability to encode functional proteins. There are no known protein products, biological roles, or disease associations for this locus, nor is it considered a therapeutic target[2]. The gene’s current official name is “Pseudogene containing WD repeat domains” according to major gene databases[2]. It is explicitly classified as a pseudogene, which means it does not encode a functional protein and does not act as a receptor, enzyme, transporter, or any defined therapeutic target[2]. No alternative names (aliases) are listed apart from a previous GeneCards identifier (GC03M122135)[2]. No biological function, disease involvement, or drug interaction is known or cataloged for this pseudogene[2]. The presence of WD repeat domains in the name reflects sequence similarity but does not indicate any functional activity. WD repeat domains in general (unrelated to this pseudogene) are structural motifs found in a large, versatile family of proteins with important cellular and disease-related functions, but this does not apply to ENSG00000242531 specifically[3][6]. Because this gene is a pseudogene and not a functional gene or target, it does not map to any of the canonical druggable families or functions (such as “G protein-coupled receptor,” “Ion channel,” etc.). If seeking a functional WD repeat domain protein, other genes like WDR5, WDR18, or WDR7 are biologically relevant, but ENSG00000242531 is not[2][3][4]. In summary: ENSG00000242531 is a non-functional pseudogene with WD repeat domain similarity, not a target, not associated with disease or therapy, and should not be used as a canonical molecular target in drug discovery or biomarker applications[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene containing WD repeat domains.